宠物食品八大禁 忌，你踩坑了 吗？_南方+_南 方plus 随着生活水平提 升，宠物早已成 为不少家庭 的"毛孩子"，在 生活中占据重要 地位。《2026年 中国宠物行业白 皮书（消费报 告）》显示，城 镇犬猫总数已达 1.26亿只！但很 多人养宠全凭一 腔热爱，却忽略 了关键的饮食常 要知道，宠物和 人类的生理结构 差别很大，不少 识。 我们常吃的美 食，对它们来说 就是"隐形毒 药"——轻则上 吐下泻，重则器 官衰竭危及生 命。今天就来盘 点宠物饮食的八 大禁忌，养宠人 速来避坑！ 禁忌一 体内不断堆积， 刺激中枢神经和 心血管系统。其 中黑巧克力、可 可粉毒性最强， 一旦误食，会出 现呕吐、腹泻、 心跳加速、抽搐 甚至昏迷，最终 可能因心脏衰竭 丧命，所有常见 宠物都要严格避 开。 禁忌二 葡萄及葡 萄干 颗颗 藏风险 很多家长觉得葡 萄营养丰富，给 毛孩子吃也没问 题，这可大错特 错！虽然科学界 还没明确葡萄的 毒性成分，但可 以确定的是，它 会直接损伤宠物 巧克力 甜 蜜的致命 诱惑 巧克力是人类的 甜蜜零食，但对 毛孩子来说，却 是剧毒之物。因 为宠物（尤其是 猫狗）体内缺少 分解可可碱和咖 啡因 ...

12月30日，华康股份跌1.06%，截至发稿，报14.92元/股，成交377.55万元，换手率0.08%，总市值45.22 亿元。 华夏卓越成长混合A（024928）成立日期2025年8月12日，最新规模9.56亿。成立以来收益16.17%。 资料显示，浙江华康药业股份有限公司位于浙江省开化县华埠镇华工路18号，成立日期2001年7月10 日，上市日期2021年2月9日，公司主营业务涉及木糖醇、山梨糖醇、麦芽糖醇、果葡糖浆等多种功能性 糖醇、淀粉糖产品的研发、生产、销售。主营业务收入构成为：晶体糖醇产品54.36%，液体糖、醇及 其他产品32.46%，其他13.18%。 从华康股份十大流通股东角度 数据显示，华夏基金旗下1只基金位居华康股份十大流通股东。华夏卓越成长混合A（024928）三季度 新进十大流通股东，持有股数415.33万股，占流通股的比例为1.39%。根据测算，今日浮亏损失约66.45 万元。 华夏卓越成长混合A（024928）基金经理为钟帅。 截至发稿，钟帅累计任职时间5年157天，现任基金资产总规模132.6亿元，任职期间最佳基金回报 184.12%， 任职期间最差基金回报-0.15%。 从 ...

Core Viewpoint - Huakang Co., Ltd. has decided to terminate the planned acquisition of 100% equity in Yuxin Sugar Alcohol due to significant changes in the market environment since the initial planning phase, despite the transaction being in progress for over a year [2][4]. Group 1: Transaction Details - The company intended to acquire Yuxin Sugar Alcohol for a total price of 1.098 billion yuan through a combination of issuing shares and cash payments [2]. - The assessment value of Yuxin Sugar Alcohol's 100% equity as of December 31, 2024, was 1.101 billion yuan, reflecting an increase of 556 million yuan and an appreciation rate of 102.01% [2][3]. Group 2: Company Performance - Huakang Co., Ltd. has faced a situation of increasing revenue without corresponding profit growth, with a revenue increase of 0.93% to 2.808 billion yuan in 2024, while net profit decreased by 27.72% to 268 million yuan [4]. - In the first three quarters of 2025, the company reported a revenue of 2.959 billion yuan, a year-on-year increase of 40.52%, but net profit declined by 9.91% to 168 million yuan [4]. Group 3: Industry Context - The company and Yuxin Sugar Alcohol are recognized as leading firms in the production and technology of xylitol, with the acquisition aimed at enhancing market competitiveness and operational efficiency [4]. - The industry is currently facing challenges, including a major customer of Yuxin Sugar Alcohol experiencing a debt crisis, which may impact the market dynamics [4].

Core Viewpoint - Huakang Co., Ltd. has terminated its acquisition of Henan Yuxin Sugar Alcohol Co., Ltd. after a year of planning, citing significant changes in the market environment since the initial planning phase [1][3]. Group 1: Acquisition Details - The acquisition was initiated on October 26, 2024, with a transaction price of approximately 1.098 billion yuan, which would have made Yuxin Sugar Alcohol a wholly-owned subsidiary of Huakang [3]. - Yuxin Sugar Alcohol is recognized in the functional sugar alcohol industry, with high production technology and significant xylitol capacity, contributing to Huakang's competitive advantage in the domestic and international markets [3]. Group 2: Financial Performance - Huakang's revenue for 2024 was 2.808 billion yuan, a slight increase of 0.93% year-on-year, while the net profit attributable to shareholders decreased by 27.72% to 268 million yuan [4]. - In the first three quarters of 2025, the company achieved revenue of 2.959 billion yuan, a year-on-year increase of 40.52%, but the net profit attributable to shareholders fell by 9.91% to 168 million yuan [4]. Group 3: Future Growth Strategies - The company is focusing on the release and digestion of its own production capacity, particularly through the construction of a 2 million-ton corn deep processing health food ingredient project in Zhoushan, Zhejiang [5]. - The first phase of the project, with a capacity of 1 million tons, has been completed, and the company is gradually increasing production efficiency [5]. - To improve profitability, the company needs to focus on high-growth application scenarios, optimize its product matrix, and strengthen supply chain collaboration to reduce costs [5].

Core Insights - The trend of young consumers moving away from "sugar-free" products is evident, with a noticeable slowdown in the growth of sugar-free tea sales and a decline in the popularity of sugar substitutes [5][12][14] Industry Overview - Sugar-free tea sales growth has significantly decreased, with sales growth rates from April to September 2023 being 3.9%, 7%, 19.9%, 19.5%, 8.5%, and 6.3%, all lower than the same periods in the previous year [2] - The average price of sugar-free tea has been on the rise, increasing from 5.1 yuan per piece in 2023 to 5.6 yuan per piece by 2025, indicating that despite higher prices, total sales growth is slowing [2] - The market is dominated by established brands like Nongfu Spring and Suntory, which together hold 87.3% market share as of September 2023, up 6.4% from the previous year [7] - The second-tier brands' market share has decreased from 11.3% to 7.4%, while the third-tier brands' share has shrunk from 5.1% to 3.4%, highlighting the intensifying head effect in the industry [7][9] Consumer Behavior - The shift in consumer preferences indicates that the younger generation is moving away from extreme health consciousness towards a more indulgent lifestyle, seeking comfort in sugary beverages [5][12] - The demand for sugar substitutes, particularly erythritol, has also faced challenges, with a reported oversupply in the market as of May 2023, where domestic production capacity reached 380,000 tons per year against a global demand of only 173,000 tons [2][14] Product Innovation - There has been a lack of new hit products in the sugar-free tea market, with established products like unsweetened oolong and jasmine tea dominating nearly 70% of the market share [9] - The innovation in the sugar-free tea sector has stagnated, with brands focusing on minor innovations around existing products rather than developing new ones, leading to potential homogenization and price competition [9][11] - In contrast, the sugary tea segment has seen a surge in new product launches, with sugary tea products outnumbering sugar-free tea products significantly in recent months [10] Supplier Challenges - Suppliers of sugar substitutes are experiencing significant operational pressures, with major companies like San Yuan Bio reporting a 7.54% decline in total revenue and a 16.8% drop in net profit for the first three quarters of the year [14][19] - The industry is facing a broader trend of declining demand, leading to increased competition and financial strain on suppliers, many of whom are exploring alternative products and markets to mitigate losses [17][19]

Investment Rating - The report maintains an "Accumulate-A" rating for the company [2][8]. Core Views - The company is expected to benefit from the rapid growth in advanced electronic materials and battery materials, driven by increasing demand from AI servers and the rising penetration of new energy battery materials [5]. - The company has shown robust growth in synthetic resin sales and continues to expand its product categories, effectively responding to market changes [4]. - The company is enhancing its production capacity, with several projects underway that are expected to contribute significantly to future revenue and profit growth [5][6]. Financial Performance - For the first three quarters of 2025, the company achieved revenue of 8.072 billion yuan, a year-on-year increase of 12.87%, and a net profit attributable to shareholders of 760 million yuan, up 30.81% year-on-year [3]. - In Q3 2025, the company reported revenue of 2.722 billion yuan, a 7.75% increase year-on-year, but a 5.89% decrease quarter-on-quarter [3]. Product and Market Development - The company’s synthetic resin sales reached 588,700 tons in the first three quarters of 2025, representing a 13.90% year-on-year increase, with sales revenue of 4.096 billion yuan, up 4.64% year-on-year [4]. - The company is focusing on high-end product development and expanding its product applications in various sectors, including phenolic resin and casting materials [4]. Capacity Expansion and Future Outlook - The company is expanding its production capacity for advanced electronic materials and battery materials, with several projects expected to be completed by Q3 2026 [5]. - The company plans to raise up to 2.5 billion yuan through convertible bonds, with 2 billion yuan allocated for the industrialization of green new energy battery materials, projected to generate significant annual revenue and profit [5]. Financial Projections - The company is projected to achieve revenues of 11.786 billion yuan, 13.049 billion yuan, and 14.216 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding net profits of 1.181 billion yuan, 1.449 billion yuan, and 1.681 billion yuan [8][10].

Group 1: Industry Overview - The Chinese sugar substitute industry has a competitive hierarchy, with companies having registered capital exceeding 500 million yuan, such as Rhein Biotech, Jinhui Industrial, and Morning Light Biological, while those with capital between 200 million to 500 million yuan include Baolingbao and Bailong Chuangyuan [1] - The primary production regions for sugar substitute companies in China are Shandong, Hebei, and Anhui provinces, with Shandong housing the most companies, including Sanyuan Biological, Baolingbao, and Bailong Chuangyuan [1] Group 2: Revenue Rankings - In 2024, Huakang Co., Ltd. leads the revenue ranking among listed sugar substitute companies in China, with sales exceeding 1.9 billion yuan. Baolingbao, Rhein Biotech, and Sanyuan Biological follow, each with revenues exceeding 500 million yuan [5] Group 3: Industry Concentration - The concentration levels in the sugar substitute industry are high for products like sucralose, aspartame, and sugar alcohols. Major manufacturers of sucralose include Jinhui Industrial and Shandong Kangbao, while aspartame is primarily produced by companies like Hanguang Sweeteners and the Vito Company [8] Group 4: Company Layout - Companies like Sanyuan Biological and Huakang Co., Ltd. have a high proportion of their business in sugar substitutes. Many companies focus on sugar alcohol products, with Huakang Co., Ltd. producing over 170,000 tons of crystalline sugar alcohol [9][11] - Key sales markets for Chinese sugar substitute companies include China, the Americas, Europe, and Japan and South Korea [9] Group 5: Competitive Analysis - The competitive state of the sugar substitute industry in China shows moderate competition among existing firms, with a significant threat from potential new entrants due to growing health demands [12] - The bargaining power of upstream suppliers is strong, as the main raw materials are sourced from starch and chemical raw material companies, which are generally larger than the sugar substitute manufacturers [12] - The bargaining power of downstream customers is relatively weak, especially for small clients, while industry leaders maintain some pricing power [12]

Core Viewpoint - The company reported a slight decline in Q3 net profit due to falling prices of synthetic resin products, but overall performance in the first three quarters shows growth in revenue and profit, indicating potential for recovery in the future [1][4]. Financial Performance - Q3 revenue reached 2.722 billion yuan, a year-on-year increase of 7.75% but a quarter-on-quarter decrease of 5.89% [1]. - Q3 net profit was 259 million yuan, up 3.73% year-on-year but down 12.10% quarter-on-quarter [1]. - For the first three quarters of 2025, revenue totaled 8.072 billion yuan, a year-on-year increase of 12.87%, with net profit at 760 million yuan, up 30.81% year-on-year [1]. Segment Performance - Advanced electronic materials and battery materials saw significant demand growth, with sales volume reaching 60,000 tons, a 19% year-on-year increase, and sales revenue of 1.2 billion yuan, up 32% [2]. - The synthetic resin sector maintained resilience, achieving sales volume of 590,000 tons, a 14% year-on-year increase, and sales revenue of 4.1 billion yuan, up 5% [2]. - Biomass products recorded sales volume of 170,000 tons, a 30% year-on-year increase, with sales revenue of 700 million yuan, up 25% [2]. Project Development - The company is advancing several key projects, including a 2,000 tons/year PPO/OPE resin project and a 1,000 tons/year carbon hydrogen resin project, expected to be operational by Q3 2026 [3]. - The biomass production base is running steadily, with expansion projects for xylitol expected to be operational by the end of 2025 and the second half of 2026 [3]. - The company plans to issue convertible bonds to invest in green energy battery material projects, which will enhance production capacity significantly [3]. Profit Forecast and Valuation - Due to short-term demand weakness, the net profit forecast for 2025 has been revised down to 1.09 billion yuan, a 9% decrease from the previous estimate [4]. - The company expects net profits for 2025, 2026, and 2027 to be 1.09 billion, 1.39 billion, and 1.61 billion yuan respectively, with corresponding EPS of 1.28, 1.64, and 1.90 yuan [4]. - A target price of 39.36 yuan has been set based on a 24x PE valuation for 2026, maintaining an "overweight" rating [4].

Core Insights - Jinan Shengquan Tanghe Tang Biotechnology Co., Ltd. has evolved from a sales revenue of only 10 million yuan in its founding year (2008) to a leading enterprise in the functional sugar and sugar alcohol industry, with a target output value exceeding 1 billion yuan in the next 3-5 years [1][3] Group 1: Company Overview - The company is supported by its parent company, Shengquan Group, leveraging patented technology known as "Shengquan Method" for high-value utilization of agricultural straw [3] - The unique technology allows for the extraction of high-purity D-Xylose and L-Arabinose from hemicellulose, leading to the production of Xylitol for global food enterprises [3][4] Group 2: Production and Sustainability - The company achieves over 95% utilization of agricultural straw, enabling the production of multiple products from the same raw materials, which is a significant competitive advantage [3] - Through self-built power plants and steam equipment, the company has implemented a low-carbon emission strategy and has received carbon footprint certification for its sustainable practices [3] Group 3: Growth and Market Expansion - In 2021, the company invested heavily in a fully automated 15,000-ton Xylitol production line, which significantly increased market acceptance and expanded its customer base internationally, raising its output value from 100 million yuan to over 400 million yuan [4] Group 4: Competitive Differentiation - The company differentiates itself in a competitive functional sugar market through three main strategies: advanced production processes, continuous scientific validation, and application innovation [6] - The proprietary extraction process ensures higher quality and safety, while partnerships with research institutions enhance product functionality and safety [6][7] Group 5: Health and Application - The company is actively exploring applications of functional sugars in health products, pharmaceuticals, and specialized nutrition for the elderly, contributing to the health initiatives in China [7]

Group 1 - The core viewpoint of the news is that Huakang Co., Ltd. has seen a significant increase in its stock price, rising by 5.28% to 18.35 CNY per share, with a total market capitalization of 5.561 billion CNY [1] - Huakang Co., Ltd. specializes in the research, production, and sales of various functional sugar alcohols and starch sugar products, with its main business revenue composition being 54.36% from crystalline sugar alcohol products, 32.46% from liquid sugars and alcohols, and 13.18% from other products [1] - The company is located in Kaifa County, Zhejiang Province, and was established on July 10, 2001, with its listing date on February 9, 2021 [1] Group 2 - From the perspective of fund holdings, one fund under Wan Jia Fund has a significant position in Huakang Co., Ltd., with the Wan Jia Quantitative Tongshun A fund holding 44,000 shares, accounting for 0.98% of the fund's net value, making it the second-largest holding [2] - The Wan Jia Quantitative Tongshun A fund has a total scale of 28.1768 million CNY and has achieved a year-to-date return of 16.29%, ranking 4630 out of 8162 in its category [2] - The fund has a one-year return of 30.77%, ranking 2195 out of 8024, and a cumulative return since inception of 49.82% [2]